Gateway Investment Advisers LLC Dexcom Inc Transaction History

Gateway Investment Advisers LLC

$9 Billion
Q3 2024

A detailed history of Gateway Investment Advisers LLC transactions in Dexcom Inc stock. As of the latest transaction made, Gateway Investment Advisers LLC holds 8,832 shares of DXCM stock, worth $638,023. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,832

Previous 8,092 9.14%

Holding current value

$638,023

Previous $917,000 35.55%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$64.0 - $116.06 $47,360 - $85,884	740 Added 9.14%	8,832 $591,000
Q2 2024 Jul 12, 2024	SELL	$110.31 - $140.45 $7.72 Million - $9.83 Million	-70,011 Reduced 89.64%	8,092 $917,000
Q1 2024 Apr 12, 2024	BUY	$114.22 - $140.1 $7.98 Million - $9.78 Million	69,839 Added 845.1%	78,103 $10.8 Million
Q4 2023 Jan 09, 2024	SELL	$75.49 - $124.16 $11,172 - $18,375	-148 Reduced 1.76%	8,264 $1.03 Million
Q3 2023 Oct 19, 2023	SELL	$86.06 - $137.93 $4.92 Million - $7.89 Million	-57,177 Reduced 87.17%	8,412 $784,000
Q2 2023 Jul 13, 2023	SELL	$112.47 - $130.98 $3.77 Million - $4.39 Million	-33,527 Reduced 33.83%	65,589 $8.43 Million
Q1 2023 Apr 11, 2023	BUY	$104.0 - $122.92 $1.86 Million - $2.2 Million	17,877 Added 22.01%	99,116 $11.5 Million
Q4 2022 Jan 13, 2023	BUY	$84.98 - $122.67 $6.53 Million - $9.42 Million	76,807 Added 1733.01%	81,239 $0
Q3 2022 Oct 07, 2022	SELL	$76.35 - $94.18 $83,145 - $102,562	-1,089 Reduced 19.72%	4,432 $357,000
Q2 2022 Jul 13, 2022	BUY	$67.99 - $132.89 $295,892 - $578,337	4,352 Added 372.28%	5,521 $411,000
Q1 2022 Apr 14, 2022	BUY	$94.08 - $130.2 $27,847 - $38,539	296 Added 33.91%	1,169 $598,000
Q4 2021 Jan 14, 2022	BUY	$129.87 - $162.82 $18,571 - $23,283	143 Added 19.59%	873 $469,000
Q3 2021 Oct 22, 2021	SELL	$106.71 - $143.18 $1,387 - $1,861	-13 Reduced 1.75%	730 $399,000
Q2 2021 Jul 13, 2021	SELL	$80.99 - $107.93 $2,267 - $3,022	-28 Reduced 3.63%	743 $317,000
Q1 2021 Apr 14, 2021	SELL	$84.79 - $104.74 $13,905 - $17,177	-164 Reduced 17.54%	771 $277,000
Q4 2020 Jan 14, 2021	SELL	$78.0 - $104.5 $3,978 - $5,329	-51 Reduced 5.17%	935 $346,000
Q3 2020 Oct 19, 2020	BUY	$95.51 - $112.95 $18,815 - $22,251	197 Added 24.97%	986 $406,000
Q2 2020 Jul 15, 2020	SELL	$62.68 - $105.34 $640,777 - $1.08 Million	-10,223 Reduced 92.84%	789 $320,000
Q1 2020 Apr 13, 2020	BUY	$47.79 - $75.63 $334 - $529	7 Added 0.06%	11,012 $2.97 Million
Q4 2019 Jan 09, 2020	SELL	$36.62 - $57.29 $418,127 - $654,137	-11,418 Reduced 50.92%	11,005 $2.41 Million
Q3 2019 Oct 15, 2019	SELL	$35.53 - $43.8 $73,689 - $90,841	-2,074 Reduced 8.47%	22,423 $3.35 Million
Q2 2019 Jul 17, 2019	BUY	$27.84 - $38.92 $105,541 - $147,545	3,791 Added 18.31%	24,497 $3.67 Million
Q1 2019 Apr 10, 2019	SELL	$28.07 - $38.18 $194,188 - $264,129	-6,918 Reduced 25.04%	20,706 $2.47 Million
Q4 2018 Jan 14, 2019	BUY	$26.99 - $37.37 $745,571 - $1.03 Million	27,624 New	27,624 $3.31 Million

Others Institutions Holding DXCM

# of Institutions

1,075

Shares Held

362M

Call Options Held

4.1M

Put Options Held

3.61M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $27.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Investment Advisers LLC with notifications on news.

Account

Gateway Investment Advisers LLC Dexcom Inc Transaction History